日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention

基于肽的CD44v6抑制作用使肝癌更容易受到治疗干预。

Srikanth, Akshaya; Rao, Ranjitha Vishnu Anand; Dong, Rui; Tharehalli, Umesh; Barth, Thomas F E; Dembowsky, Klaus; Seufferlein, Thomas; Schirmbeck, Reinhold; Lechel, André

C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function

CXC 基序趋化因子受体 4 阻断剂通过增强调节性 T 细胞动员和免疫调节功能促进心肌梗死后的组织修复

Yong Wang, Klaus Dembowsky, Eric Chevalier, Philipp Stüve, Mortimer Korf-Klingebiel, Matthias Lochner, L Christian Napp, Heike Frank, Eva Brinkmann, Anna Kanwischer, Johann Bauersachs, Mariann Gyöngyösi, Tim Sparwasser, Kai C Wollert

Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending Doses

健康成年受试者单次和多次递增剂量静脉输注莫瑞帕伐定的药代动力学和安全性

Wach, Achim; Dembowsky, Klaus; Dale, Glenn E

Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells

持续阻断CXCR4可导致造血干细胞和祖细胞的显著动员和扩增。

Karpova, Darja; Ritchey, Julie K; Holt, Matthew S; Abou-Ezzi, Grazia; Monlish, Darlene; Batoon, Lena; Millard, Susan; Spohn, Gabriele; Wiercinska, Eliza; Chendamarai, Ezhil; Yang, Wei; Christ, Stephanie; Gehrs, Leah; Schuettpelz, Laura G; Dembowsky, Klaus; Pettit, Allison R; Rettig, Michael P; Bonig, Halvard; DiPersio, John F

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial

在GMMG-MM5试验中,循环肿瘤细胞可作为多发性骨髓瘤患者治疗反应的生物标志物

Huhn, S; Weinhold, N; Nickel, J; Pritsch, M; Hielscher, T; Hummel, M; Bertsch, U; Huegle-Doerr, B; Vogel, M; Angermund, R; Hänel, M; Salwender, H J; Weisel, K; Dürig, J; Görner, M; Kirchner, H; Peter, N; Graeven, U; Lordick, F; Hoffmann, M; Reimer, P; Blau, I W; Jauch, A; Dembowsky, K; Möhler, T; Wuchter, P; Goldschmidt, H

Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination

多方面 CXC 趋化因子受体 4 (CXCR4) 抑制可干扰抗血管内皮生长因子疗法引起的胶质瘤播散

Jean-Pierre Gagner, Yasmeen Sarfraz, Valerio Ortenzi, Fawaz M Alotaibi, Luis A Chiriboga, Awab T Tayyib, Garry J Douglas, Eric Chevalier, Barbara Romagnoli, Gérald Tuffin, Michel Schmitt, Guillaume Lemercier, Klaus Dembowsky, David Zagzag

Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma

VEGF 和 CXCR4 联合拮抗剂靶向 GBM 干细胞群,协同提高颅内胶质母细胞瘤小鼠模型的生存率

Amy Barone, Rajarshi Sengupta, Nicole M Warrington, Erin Smith, Patrick Y Wen, Rolf A Brekken, Barbara Romagnoli, Garry Douglas, Eric Chevalier, Michael P Bauer, Klaus Dembowsky, David Piwnica-Worms, Joshua B Rubin

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

新型 CXCR4 拮抗剂 POL5551 比 Plerixafor 更有效地动员造血干细胞和祖细胞

D Karpova, K Dauber, G Spohn, D Chudziak, E Wiercinska, M Schulz, A R Pettit, J P Levesque, B Romagnoli, K Patel, E Chevalier, K Dembowsky, H Bonig

Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium

心肌细胞周期激活可改善心房纤维化

Nakajima, Hidehiro; Nakajima, Hisako O; Dembowsky, Klaus; Pasumarthi, Kishore B S; Field, Loren J

Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies

新型NO非依赖性鸟苷酸环化酶刺激剂BAY 41-8543的药理作用:体外研究

Stasch, Johannes-Peter; Alonso-Alija, Cristina; Apeler, Heiner; Dembowsky, Klaus; Feurer, Achim; Minuth, Torsten; Perzborn, Elisabeth; Schramm, Matthias; Straub, Alexander